He’s using Biden-era mistakes to tarnish a promising technology.

Multiple scientists and doctors have spoken out against this decision, including infectious diseases expert Dr. Thomas A. Russo, who told Newsweek that mRNA vaccines "will be critical when the next, ...

The technology once embraced by President Donald Trump for speeding the development of COVID-19 vaccines is now under scrutiny. Health Secretary Robert F. Kennedy Jr. recently took sweeping action ...

COVID-19 vaccine proves cost-effective, especially for older adults, significantly reducing illness and hospitalizations across all age groups.

The US health secretary has cancelled research into mRNA vaccines, but his reasons seem to be based on bad information about ...

Health and Human Services Secretary Robert F. Kennedy Jr. has halted nearly half a billion dollars in funding for mRNA-based respiratory vaccines—and thereby ended America’s leadership research into ...

When they were created at the beginning of the COVID-19 pandemic, mRNA vaccines to treat the virus were considered a major ...

For the first time in three decades, the American Academy of Pediatrics is substantially diverging from U.S. government ...

Routine screening, early detection, and prompt treatment of infections can help limit spread, and non-mRNA options like viral vector vaccines can strengthen population immunity.

Novavax, Inc. (NASDAQ:NVAX) is a biotechnology company focused on recombinant protein-based vaccines using nanoparticle and ...

Following the criticism of mRNA vaccine strategies by federal leaders, UNC Health's Dr. David Wohl shared why he supports the research.

Heading into the respiratory illness season, states and clinicians are working to encourage pregnant patients to get COVID-19 ...